APA (7th ed.) Citation

Lu, N., Lu, N., Zhang, Y., Wang, C., Yang, Q., Rong, G., . . . Han, W. (2025). Balance and management of CRS and infection following CD19-targeted CAR T-cell therapy in primary refractory high-grade B-cell lymphoma: A case report. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Lu, Nannan, Nannan Lu, Yajing Zhang, Chunmeng Wang, Qingming Yang, Guanghua Rong, Yang Liu, Weidong Han, and Weidong Han. Balance and Management of CRS and Infection Following CD19-targeted CAR T-cell Therapy in Primary Refractory High-grade B-cell Lymphoma: A Case Report. Frontiers Media S.A, 2025.

MLA (9th ed.) Citation

Lu, Nannan, et al. Balance and Management of CRS and Infection Following CD19-targeted CAR T-cell Therapy in Primary Refractory High-grade B-cell Lymphoma: A Case Report. Frontiers Media S.A, 2025.